C07F 9/222
Amides of phosphoric acids
Official title: {Amides of phosphoric acids}
C07F9/222 (Amides of phosphoric acids) appears on 64 US grants and 70 published applications in this corpus.
Search patents in C07F- Granted patents
- 64
- Published applications
- 70
- Assignees
- 56
- Inventors
- 211
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 1 |
| 2009 | 0 | 3 |
| 2010 | 2 | 2 |
| 2011 | 0 | 4 |
| 2012 | 5 | 1 |
| 2013 | 0 | 6 |
| 2014 | 5 | 3 |
| 2015 | 3 | 6 |
| 2016 | 5 | 5 |
| 2017 | 1 | 4 |
| 2018 | 2 | 5 |
| 2019 | 6 | 8 |
| 2020 | 4 | 6 |
| 2021 | 7 | 2 |
| 2022 | 4 | 3 |
| 2023 | 4 | 1 |
| 2024 | 1 | 4 |
| 2025 | 1 | 0 |
| 2026 | 3 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Polyhydroxylated cyclopentane derivatives and methods of use29 Sep 2026US 12,747,257 B2Sanegene Bio USA Inc.
- Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof14 Apr 2026US 12,599,599 B2Medicon Pharmaceuticals, Inc.
- Small molecule inhibitors selective for polo-like kinase protein16 Sep 2025US 12,415,822 B2University of South Carolina
- Process for making levoamphetamine11 Jun 2024US 12,006,275 B2Pharmapotheca A, Inc.
- Indanone derivatives as nucleobase buildings block for on-dna aldehyde capture8 Jan 2026US 2026/0008796 A1University of Guelph
- Dendrimer-glutamine antagonist conjugates and methods of use thereof5 Dec 2024US 2024/0398962 A1Institute of Organic Chemistry and Biochemistry
- Small molecule inhibitors selective for polo-like kinase protein25 Jan 2024US 2024/0025930 A1University of South Carolina
- Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof18 Jan 2024US 2024/0016799 A1Medicon Pharmaceuticals, Inc.
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient cftr activity4 Jan 2024US 2024/0002374 A1Genzyme Corporation
Most cited
By later US patents
- Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups59US 8,779,128 B2Sarepta Therapeutics, Inc. · 2014
- Peptidomimetic inhibitors of PSMA, compounds comprising them, and methods of use41US 7,696,185 B2Cancer Targered Technology LLC · 2010
- Amino acid derivatives and their use as antidepressives and hypotensive agents36US 4,738,803 A1988
- Amino acid derivative32US 4,618,708 A1986
- Protective barrier composition comprising reaction of phosphorous acid with amines applied to a substrate27US 8,212,073 B22012